ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx's
There are no recent dividends present for CCXI.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.